Deborah T. Gold

Deborah T. Gold

Professor Emeritus in Psychiatry and Behavioral Sciences

External address: 
1507 Busse Bldg, Durham, NC 27710
Internal office address: 
Box 3003 Med Ctr, Durham, NC 27710
(919) 660-7530


My research has centered on the psychosocial consequences of chronic illness for older adults. Although I have studied breast cancer, syncope, head and neck cancer, Parkinson's disease and Paget's disease of bone, my primary interest and focus has been on osteoporosis and its psychological and social impact on those who suffer from it.

In particular, my current research focuses on compliance and persistence with osteoporosis medications. One current study focuses on the impact of race/ethnicity on medication decision making. We are trying to determine the relative weight of cost, convenience, dosing interval, efficacy, and safety in making medication decisions and taking medication on a regular basis as prescribed by a health care provider. I am also on the Steering Committees of two major observational studies with different osteoporosis medications.

Finally, I have worked with voluntary health organizations to translate our research findings into positive real-world outcomes for people with chronic illness. I serve on the Board of Trustees of the National Osteoporosis Foundation and am Chair of its Education Committee. I have also chaired the International Symposium on Osteoporosis (ISO) for the last 8 years.

Education & Training

  • Ph.D., Northwestern University 1986

Selected Grants

Claude D. Pepper Older American Independence Centers awarded by National Institutes of Health (Co-Principal Investigator). 1992 to 1997

Osteoporosis And Disability In A Life Care Community awarded by National Institutes of Health (Principal Investigator). 1993 to 1996

Osteoporosis And Disability In Life-Care Community Women awarded by National Institutes of Health (Principal Investigator). 1992 to 1996

Coping With Chronic Illness In Later Life awarded by National Institutes of Health (Principal Investigator). 1988 to 1989


Gold, Deborah T., et al. “A Patient Survey Study of Zoledronic Acid Utilization and Factors Associated with Persistence.Arthritis & Rheumatology, vol. 66, WILEY-BLACKWELL, Oct. 2014, pp. S509–S509.

Reynolds, Kristi, et al. “Validation of the Osteoporosis-Specific Morisky Medication Adherence Scale in long-term users of bisphosphonates.Qual Life Res, vol. 23, no. 7, Sept. 2014, pp. 2109–20. Pubmed, doi:10.1007/s11136-014-0662-3. Full Text

Naegeli, A. N., et al. “Development of the Osteoporosis Assessment Questionnaire--physical Function (OPAQ-PF): an osteoporosis-targeted, patient-reported outcomes (PRO) measure of physical function.Osteoporos Int, vol. 25, no. 2, Feb. 2014, pp. 579–88. Pubmed, doi:10.1007/s00198-013-2448-9. Full Text

George, L. K., and D. T. Gold. Life course perspectives on intergenerational and generational connections. Vol. 16, Jan. 2014, pp. 67–88. Scopus, doi:10.4324/9781315059303. Full Text

Naegeli, A. N., et al. “Development of the osteoporosis assessment questionnaire - Physical function (OPAQ-PF): An osteoporosis-targeted, patient-reported outcomes (PRO) measure of physical function.” Osteoporosis International, vol. 25, no. 2, Jan. 2014, pp. 579–88. Scopus, doi:10.1007/s00198-013-2448-9. Full Text

Reynolds, K., et al. “Primary non-adherence to bisphosphonates in an integrated healthcare setting.Osteoporos Int, vol. 24, no. 9, Sept. 2013, pp. 2509–17. Pubmed, doi:10.1007/s00198-013-2326-5. Full Text

Silverman, S., et al. “Patient weighting of osteoporosis medication attributes across racial and ethnic groups: a study of osteoporosis medication preferences using conjoint analysis.Osteoporos Int, vol. 24, no. 7, July 2013, pp. 2067–77. Pubmed, doi:10.1007/s00198-012-2241-1. Full Text

Gold, D. T. Condition Critical: Compliance and Persistence with Osteoporosis Medications. Jan. 2013, pp. 1909–21. Scopus, doi:10.1016/B978-0-12-415853-5.00082-0. Full Text